Committees

Future cancer

Inquiry

The Future Cancer inquiry will explore innovations in cancer diagnosis and treatment.

It will look at the innovations with the greatest potential to transform cancer diagnosis and treatment for patients in the short, medium and long term, and it will examine how innovations in diagnosing and treating cancer can best be transitioned into frontline clinical settings. It will also explore international examples of best practice.

Types of innovations that could be examined by the inquiry range from medicines and vaccines to artificial intelligence. 

This inquiry builds on the Committee's recent work on cancer services, including its report in April 2022, which was focused largely on current provision of cancer services and the impact of the covid-19 pandemic.

Please first read the important information on this webpage and the terms of reference on the portal page. Your submission should be no more than 3,000 words.  

 

 

This inquiry is no longer accepting evidence

The deadline for submissions was Wednesday 26 April 2023.

Upcoming events

View all events

No upcoming events scheduled

Past events

Thursday 14 September 2023
9:00am Private
9:30am Public
Future cancer - Oral evidence 14 September 2023
9:30am
  • Professor Sir John Bell (Regius Professor of Medicine at Oxford University)
  • Dr Robin Buckle (Chief Science Officer at Medical Research Council)
  • Dr Susan Galbraith (Executive Vice President of Oncology Research & Development at AstraZeneca)
  • Professor Kevin Harrington (Head of the Division of Radiotherapy and Imaging at Institute of Cancer Research)
The Grimond Room, Portcullis House
Wednesday 19 July 2023
9:30am Private
10:00am Public
Future cancer - Oral evidence 19 July 2023
10:00am
  • Professor Matt Brown (Chief Scientific Officer at Genomics England)
  • Professor Stephen Duffy (Professor of Cancer Screening at Wolfson Institute of Population Health (Queen Mary University of London))
  • Marcel Gehrung, PhD (Co-founder and Chief Executive Officer at Cyted)
  • Sara Hiom (Vice President, NHS Implementation & External Affairs at GRAIL Europe)
Room 15, Palace of Westminster
Wednesday 21 June 2023
2:00pm Private
2:30pm Public
Future cancer - Oral evidence 21 June 2023
2:30pm
  • Anna Jewell (Chair at Less Survivable Cancers Taskforce)
  • Jane Lyons (Chief Executive Officer at Cancer52)
  • Michelle Mitchell OBE (Chief Executive Officer at Cancer Research UK)
  • Gemma Peters (Chief Executive Officer at Macmillan Cancer Support)
Room 15, Palace of Westminster

Contact us

We can't usually help you with an individual problem or a specific complaint.

  • Email: hsccom@parliament.uk
  • Phone: (general enquiries) 020 7219 6182 | 020 7219 6832 (media enquiries)
  • Address: Health and Social Care Committee, House of Commons, London, SW1A 0AA